Jeffrey Leiden

About

Dr. Jeff Leiden is the Executive Chairman of Vertex Pharmaceuticals since April 2020. Previously he served as CEO and President since February 2012, and has served as a member of Vertex's board of directors since 2009. Jeff Leiden brings to Vertex more than 30 years of scientific, commercial and financial experience in the pharmaceutical and biotechnology industries and clinical experience in academia as a practicing cardiologist and molecular biologist. Previously, Jeff Leiden served as a Managing Director for Clarus Ventures, a life sciences venture capital firm he joined in 2006. In 2000, he joined Abbott Laboratories as President and Chief Operating Officer where he had responsibility for running Abbott’s global pharmaceuticals business. While at Abbott, Jeff Leiden helped launch multiple breakthrough medicines, including Humira for rheumatoid arthritis and other autoimmune diseases and Kaletra for HIV infection, among others. He also served as a member of the Board of Directo

Investment Focus

Location

Boston, US